NCD Japan Forum 2011
date : 11/29/2011
>>★Short video on the day (4 min, YouTube)
On the 29th September 2011, the Health and Global Policy Institute hosted the “NCD Forum 2011 ~ Chronic Disease Control and the NCD Agenda in Developed Countries” at the Ambassador’s Residence of the British Embassy in Tokyo.
In September, the importance of tackling non-communicable diseases (NCDs; or chronic diseases) was highlighted to the world as it became the main topic of discussion at the U.N. High Level Meeting. This forum was therefore held with a view to reminding the participants of this important issue, whilst also providing a platform for the discussion of future NCD control strategies within Japan, the sharing of perspectives and ambitions of various stakeholders in this field, and the exchange of views on the future measures to be taken by Japan.
Japan has a record of making significant contributions to infectious disease control in its role as a major donor to the U.N. In light of its knowledge in dealing with chronic disease, it is also expected that it will exert international initiative in the area of NCDs.
The Forum was opened with greetings from H.M. Ambassador David Warren and a keynote speech from Dr. Keizo Takemi, Professor at the School of Political Science and Economics at Tokai University and Senior Fellow at the Japan Center for International Exchange. This was then followed by presentations from Ms. Judith Watt, Strategic Consultant to the NCD Alliance (an international collaborative organization dealing with NCD issues), and Dr. Hajime Inoue, Director of the Department of Health and Welfare in Chiba Prefecture. Under the title “What are NCDs? – Implications for Japan and its Global Role”, Ms. Watt and Dr. Inoue served to both provide an introduction to, and also to deepen the audiences’ understanding of the current situation with NCDs.
In the latter half of the Forum, a panel discussion took place with a further four experts (Dr. Ryozo Nagai, Department of Cardiovascular Medicine, The University of Tokyo; Dr. Masato Mugitani, Assistant Minister for Global Health, Ministry of Health and Welfare; Mr. David Brennan, President, International Federation of Pharmaceutical Manufacturers & Associations (IFPMA); Ms. Loyce Pace, Director of Health Policy, Lance Armstrong Foundation), under the theme of “The Roles that should be Played by Different Sectors – Global Partnerships for NCD and Beyond”. In their positions as representatives of the different stakeholders in the NCD issue, each panelist shared their thoughts on the future contributions that can be made and the initiatives that should be undertaken from their varying perspectives. The panelists also further engaged in lively discussion and an exchange of views as to how the knowledge Japan has accumulated thus far in health policy can benefit the rest of the world in the NCD field, and the contributions it could make.
On the 29th September 2011, the Health and Global Policy Institute hosted the “NCD Forum 2011 ~ Chronic Disease Control and the NCD Agenda in Developed Countries” at the Ambassador’s Residence of the British Embassy in Tokyo.
In September, the importance of tackling non-communicable diseases (NCDs; or chronic diseases) was highlighted to the world as it became the main topic of discussion at the U.N. High Level Meeting. This forum was therefore held with a view to reminding the participants of this important issue, whilst also providing a platform for the discussion of future NCD control strategies within Japan, the sharing of perspectives and ambitions of various stakeholders in this field, and the exchange of views on the future measures to be taken by Japan.
Japan has a record of making significant contributions to infectious disease control in its role as a major donor to the U.N. In light of its knowledge in dealing with chronic disease, it is also expected that it will exert international initiative in the area of NCDs.
The Forum was opened with greetings from H.M. Ambassador David Warren and a keynote speech from Dr. Keizo Takemi, Professor at the School of Political Science and Economics at Tokai University and Senior Fellow at the Japan Center for International Exchange. This was then followed by presentations from Ms. Judith Watt, Strategic Consultant to the NCD Alliance (an international collaborative organization dealing with NCD issues), and Dr. Hajime Inoue, Director of the Department of Health and Welfare in Chiba Prefecture. Under the title “What are NCDs? – Implications for Japan and its Global Role”, Ms. Watt and Dr. Inoue served to both provide an introduction to, and also to deepen the audiences’ understanding of the current situation with NCDs.
In the latter half of the Forum, a panel discussion took place with a further four experts (Dr. Ryozo Nagai, Department of Cardiovascular Medicine, The University of Tokyo; Dr. Masato Mugitani, Assistant Minister for Global Health, Ministry of Health and Welfare; Mr. David Brennan, President, International Federation of Pharmaceutical Manufacturers & Associations (IFPMA); Ms. Loyce Pace, Director of Health Policy, Lance Armstrong Foundation), under the theme of “The Roles that should be Played by Different Sectors – Global Partnerships for NCD and Beyond”. In their positions as representatives of the different stakeholders in the NCD issue, each panelist shared their thoughts on the future contributions that can be made and the initiatives that should be undertaken from their varying perspectives. The panelists also further engaged in lively discussion and an exchange of views as to how the knowledge Japan has accumulated thus far in health policy can benefit the rest of the world in the NCD field, and the contributions it could make.
Exhibition date:2011-11-29
Top Research & Recommendations Posts
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Public Comment Submission] “The 7th Science, Technology and Innovation Basic Plan” (Draft) (February 19, 2026)
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Research Report] The 2026 Public Opinion Survey on Healthcare in Japan (February 13, 2026)
- [Policy Recommendations] Policy Recommendations in the Field of Blood Disorders “Building a Healthcare Ecosystem Centered on Patients and Those Affected” (April 13, 2026)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Public Comment Submission] R&D and Social Implementation Plan for “Achieving Carbon Neutrality in the Waste and Resource Circulation” under the Green Innovation Fund Projects (Draft Revision) (March 25, 2026)
- [Research Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Final Version) (November 14, 2024)
Featured Posts
-
2026-02-13
[Research Report] The 2026 Public Opinion Survey on Healthcare in Japan (February 13, 2026)
-
2026-04-01
[Registration Open] (Webinar) The 143rd HGPI Seminar “20 Years Since the Enactment of the Cancer Control Act: Reflecting on the Past and Envisioning the Next 20 Years” (April 28, 2026)
-
2026-04-15
[HGPI Policy Column] (No.70) — From the Planetary Health Project “Part 17: The Lancet Countdown: A ‘Lifeline’ for Health and Economy Brought about by Climate Action”









